Considerations in glaucoma therapy: fixed combinations versus their component medications

Fixed combinations of medications that lower intraocular pressure (IOP) are increasingly used in the treatment of glaucoma and ocular hypertension and offer several potential advantages over combined use of the separate component medications including enhanced convenience, improved adherence, reduced exposure to preservatives, and possible cost savings. This review aims to examine the current role of IOP-lowering fixed combinations in disease management. The results of studies that compared the efficacy and safety of IOP-lowering fixed combinations with their component medications are summarized, including those fixed combinations that consist of a prostaglandin analog and timolol. The fixed combinations currently available for use in the United States are fixed-combination dorzolamide/timolol (FCDT) and fixed-combination brimonidine/timolol (FCBT). Both of these fixed combinations reduce IOP more effectively than their component medications used separately as monotherapy. FCBT therapy also demonstrates a more favorable safety profile and reduced ocular allergy compared to monotherapy with brimonidine, a component medication. Few studies have directly compared the efficacy and safety of FCDT and FCBT, but available evidence suggests that FCBT is at least as effective as FCDT in lowering IOP and is more comfortable and better tolerated. Additional studies are needed to further evaluate the comparative efficacy and tolerability of FCDT and FCBT in the management of glaucoma and ocular hypertension.

• Publication year

  2009

• Venue

  Clinical Ophthalmology

• Publication date

  2009-12-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.2147/OPTH.S6645PMID 20169043PMCID 2819763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Three-month, randomized, parallel-group comparison of brimonidine–timolol versus dorzolamide–timolol fixed-combination therapy*

  2009cited by this paper
• Effectiveness and Safety of Dorzolamide – Timolol Alone or Combined with Latanoprost in Open-Angle Glaucoma or Ocular Hypertension

  2008cited by this paper
• Cost analysis of glaucoma medications.

  2008cited by this paper
• Comparison of allergy rates in glaucoma patients receiving brimonidine 0.2% monotherapy versus fixed-combination brimonidine 0.2%-timolol 0.5% therapy.

  2008cited by this paper
• Cost analysis of glaucoma medications.

  2008cited by this paper
• Bimatoprost/Timolol Fixed Combination: A 3-month Double-masked, Randomized Parallel Comparison to Its Individual Components in Patients With Glaucoma or Ocular Hypertension

  2007cited by this paper
• Race/Ethnicity and Nonadherence to Prescription Medications Among Seniors: Results of a National Study

  2007cited by this paper
• Ocular Comfort of Combination Glaucoma Therapies: Brimonidine 0.2%/Timolol 0.5% Compared with Dorzolamide 2%/Timolol 0.5%

  2007cited by this paper
• A Double-Masked, Randomized, Parallel Comparison of a Fixed Combination of Bimatoprost 0.03%/Timolol 0.5% with Non-Fixed Combination use in Patients with Glaucoma or Ocular Hypertension

  2007cited by this paper
• Comparing the fixed combination brimonidine-timolol versus fixed combination dorzolamide-timolol in patients with elevated intraocular pressure*

  2007cited by this paper
• Efficacy of latanoprost or fixed-combination latanoprost-timolol in patients switched from a combination of timolol and a nonprostaglandin medication.

  2006cited by this paper
• Patient-reported behavior and problems in using glaucoma medications.

  2006cited by this paper
• Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.

  2006cited by this paper
• The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.

  2005cited by this paper
• A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components.

  2005cited by this paper
• 12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertension.

  2005cited by this paper
• A Three-Month, Multicenter, Double-Masked Study of the Safety and Efficacy of Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution Compared to Travoprost 0.004% Ophthalmic Solution and Timolol 0.5% Dosed Concomitantly in Subjects With Open Angle Glaucoma or Ocular Hypertension

  2005cited by this paper
• Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.

  2005cited by this paper
• First-choice treatment preferences for primary open-angle glaucoma in the United Kingdom

  2005cited by this paper
• 12-Week Study Comparing the Fixed Combination of Brimonidine and Timolol with Concomitant Use of the Individual Components in Patients with Glaucoma and Ocular Hypertension

  2005cited by this paper
• Rate and determinants of 10-year persistence with antihypertensive drugs

  2005cited by this paper
• Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?

  2005cited by this paper
• Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review.

  2005cited by this paper
• Comparing the fixed combination dorzolamide–timolol (Cosopt®) to concomitant administration of 2% dorzolamide (Trusopt®) and 0·5% timolol – a randomized controlled trial and a replacement study

  2004cited by this paper
• A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension

  2004cited by this paper
• Medical therapy cost considerations for glaucoma.

  2003cited by this paper
• Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy.

  2003cited by this paper
• Comparison of the Efficacy of the Fixed-Combination Timolol/Dorzolamide Versus Concomitant Administration of Timolol and Dorzolamide

  2003cited by this paper
• Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial.

  2002cited by this paper
• A comparison of the fixed combination of latanoprost and timolol with its individual components

  2002cited by this paper
• A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension.

  2000cited by this paper
• Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: results from two multicenter comfort studies. Brinzolamide Comfort Study Group.

  2000cited by this paper
• Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: results from two multicenter comfort studies. Brinzolamide Comfort Study Group.

  2000cited by this paper
• A comparison of dorzolamide-timolol combination versus the concomitant drugs.

  2000cited by this paper
• A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.

  1998cited by this paper
• Comparison of the safety and efficacy of the fixed combination of dorzolamide/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study

  1998cited by this paper
• Randomised prospective masked study comparing patient comfort following the instillation of topical proxymetacaine and amethocaine

  1998cited by this paper
• A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Dorzolamide-Timolol Combination Study Group.

  1998cited by this paper
• A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group.

  1998cited by this paper
• The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.

  1998cited by this paper
• The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group.

  1998cited by this paper
• A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.

  1998cited by this paper
• Compliance in patients prescribed eyedrops for glaucoma.

  1995cited by this paper
• A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.

  1995cited by this paper

• Fixed Triple-Combination Bimatoprost/Brimonidine/Timolol Versus Separate Administration in Glaucoma: Randomized Clinical Trial.

  2026cites this paper
• Maximum Tolerated Medical Therapy for Glaucoma: Fixed-Dose Combinations of Timolol, Dorzolamide, Brimonidine with Latanoprost Versus Timolol, Dorzolamide with Latanoprost

  2025cites this paper
• Simultaneous determination of brinzolamide, timolol maleate and its oxidative degradation product using univariate and multivariate green spectrophotometric methods

  2025cites this paper
• A Comprehensive Review of Recent Advances in Minimally Invasive Glaucoma Surgery: Current Trends and Future Directions

  2024cites this paper
• Glaucoma: Current and New Therapeutic Approaches

  2024cites this paper
• Randomized Clinical Trial of Intraocular Pressure-Lowering Medications on Preventing Spikes in Intraocular Pressure Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections

  2024cites this paper
• Dementia and glaucoma: Results from a Nationwide French Study between 2006 and 2018

  2024cites this paper
• Fixed versus Unfixed Combination of Topical Latanoprost/Timolol for Glaucoma: An Observational Study Investigating the Level of Adherence and Ocular Surface Health

  2023cites this paper
• Complex ophthalmic formulation technologies: Advancement and future perspectives

  2023cites this paper
• Pharmacologic Mydriasis and Cycloplegia: A Review of Novel Delivery Devices

  2023cites this paper
• Electrosprayed core-shell nanoparticles for sustained release fixed combination monotherapy in glaucoma treatment

  2023cites this paper
• Hot-melt extruded in situ gelling systems (MeltDrops Technology): Formulation development, in silico modelling and in vivo studies.

  2023cites this paper
• A randomized clinical trial comparing three fixed combinations of bimatoprost with timolol in patients with open-angle glaucoma or ocular hypertension

  2023cites this paper
• Dry Eye Disease among Patients with Glaucoma under Topical Antiglaucoma Agents in a Tertiary Care Centre: A Descriptive Cross-sectional Study

  2022cites this paper
• Medical therapy for glaucoma: A review

  2022cites this paper
• Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients

  2022cites this paper
• Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol in Glaucoma and Ocular Hypertension in India: A Multicenter, Open-Label, Phase 3 Study

  2022cites this paper
• Tolerability in Glaucoma Patients Switched from Preserved to Preservative-Free Prostaglandin-Timolol Combination: A Prospective Real-Life Study

  2022cites this paper
• Comparative study to assess efficacy and safety of brinzolamide1% and timolol0.5% fixed combination eye drops versus dorzolamide2% and timolol0.5% fixed combination eye drops in management of open-angle glaucoma

  2022cites this paper
• Ocular microemulsion of brinzolamide: Formulation, physicochemical characterization, and in vitro irritation studies based on EpiOcular™ eye irritation assay

  2021cites this paper
• Effectiveness and Safety Verification of Brinzolamide Combination Therapy on Primary Open-angle Glaucoma or Ocular Hypertension: A Systematic Review and Meta-analysis Study

  2021cites this paper
• The Intraocular Pressure Lowering Effect of a Dual Kinase Inhibitor (ITRI-E-(S)4046) in Ocular Hypertensive Animal Models

  2021cites this paper
• Cataract extraction and intraocular pressure-lowering agents delivery: A nationwide French study between 2005 and 2017

  2021cites this paper
• Updated Prevalence and Management of Glaucoma in Elderly

  2021cites this paper
• Effectiveness and tolerability of netarsudil in combination with other ocular hypotensive agents.

  2021cites this paper
• Comparison of preserved bimatoprost 0.01% with preservative-free tafluprost: A randomised, investigator-masked, 3-month crossover, multicentre trial, SPORT II

  2021cites this paper
• Simultaneous determination of dorzolamide and timolol by first-order derivative UV spectroscopy in simulated biological fluid for in vitro drug release testing.

  2021cites this paper
• Efficacy and safety of fixed-combination brimonidine tartrate/timolol maleate in primary open-angle glaucoma, including normal-tension glaucoma

  2021cites this paper
• Can dorzolamide/timolol-fixed combination effectively treat primary open-angle glaucoma?

  2020cites this paper
• Effect of brimonidine tartrate on basophil activation in glaucoma patients.

  2020cites this paper
• Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2

  2020cites this paper
• Naturalistic Evaluation of Prescription Pattern in Glaucoma Clinic of a Tertiary Care Hospital: A Developing Country’s Perspective

  2020cites this paper
• Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension

  2020cites this paper
• Adherence and Persistence with First-Line Therapy and Compliance with Glaucoma Guidelines Using Japanese Health Care/Pharmacy Claims Database

  2020cites this paper
• A protocol for systematic review and meta-analysis

  2020cites this paper
• TIMOLOL IN GLAUCOMA: REPORT FROM A TERTIARY CARE HOSPITAL

  2020cites this paper
• OPTH_A_231402 221..230

  2020cites this paper
• Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future

  2020cites this paper
• Selective Laser Trabeculoplasty Versus Brimonidine Tartrate 0.2%/Timolol Maleate 0.5% As Adjunct Therapy in Primary Open Angle Glaucoma: A Randomized Prospective Trial

  2020cites this paper
• Dorzolamide/Timolol-Fixed Combination For Primary Open-Angle Glaucoma: A Protocol For Systematic Review

  2020cites this paper
• Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review

  2020cites this paper
• [Preservative-free fixed combination in the treatment of open-angle glaucoma and ocular hypertension: the VISIONARY Study (EUPAS22204)].

  2020cites this paper
• All About Prostaglandin Analogues in Eye

  2020cites this paper
• Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil☆.

  2020cites this paper
• Evolution of the treatment paradigm for maximum medical therapy in glaucoma

  2019cites this paper
• A nationwide survey of factors influencing adherence to ocular hypotensive eyedrops in Japan

  2019cites this paper
• Brinzolamide–loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests

  2019cites this paper
• Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension.

  2019cites this paper
• Eye Drops: Must-Knows for Anesthesiology and Perioperative Care.

  2019cites this paper
• Treatment choices for newly diagnosed primary open angle and ocular hypertension patients

  2019cites this paper
• A (randomized/prospective/pilot) study comparing the efficacy of Selective Laser Trabeculoplasty versus brimonidine tartrate 0.2%/timolol maleate 0.5% (Combigan, Allergan inc. Irvine, CA/USA) in lowering intraocular pressure as adjunct therapy in Primary Open Angle Glaucoma.

  2019cites this paper
• A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination in Patients with Controlled Primary Open-Angle Glaucoma

  2018cites this paper
• The Role of Minimally Invasive Glaucoma Surgery Devices in the Management of Glaucoma

  2018cites this paper
• [The role of fixed dose combinations in the treatment of primary open-angle glaucoma].

  2018cites this paper
• Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation

  2018cites this paper
• Patient satisfaction with fixed-combination bimatoprost/timolol ophthalmic solution: a survey study in patients with glaucoma in China

  2017cites this paper
• The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study

  2017cites this paper
• Morphological and Functional Changes of Locus Coeruleus in Patients with Primary Open-Angle Glaucoma and Animal Models.

  2017cites this paper
• Prescribing pattern and adverse events of drugs used in patients with primary open-angle glaucoma (POAG) attending a tertiary care hospital: Retrospective study -

  2017cites this paper
• Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study

  2017cites this paper
• Achievements and Limits of Current Medical Therapy of Glaucoma.

  2017cites this paper
• The Role of Cochlin in the Trabecular Meshwork

  2017cites this paper
• A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure

  2017cites this paper
• Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy

  2017cites this paper
• Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue

  2016cites this paper
• Treat primary open-angle glaucoma based on needs of the individual, taking potential adherence problems into account

  2016cites this paper
• Special considerations for glaucoma management in the elderly

  2016cites this paper
• Preservative-free tafluprost/timolol fixed combination: a new opportunity in the treatment of glaucoma

  2016influential citation
• Cardiac safety of ophthalmic timolol

  2016cites this paper
• Pharmacokinetics, Efficacy, and Safety of the Preservative-free Fixed Combination of Tafluprost 0.0015 % and Timolol 0.5 % in Healthy Volunteers: A Phase I Comparison vs. the Corresponding Preservative-free Monotherapies

  2016cites this paper
• A Randomized Trial of Fixed-Dose Combination Brinzolamide 1%/Brimonidine 0.2% as Adjunctive Therapy to Travoprost 0.004.

  2016cites this paper
• Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy

  2015cites this paper
• Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy

  2015cites this paper
• Brinzolamide/Brimonidine: A Review of Its Use in Patients with Open-Angle Glaucoma or Ocular Hypertension

  2015cites this paper
• Treat primary open-angle glaucoma based on needs of the individual, taking potential adherence problems into account

  2015cites this paper
• Volumetric and cost evaluation study of glaucoma medical therapy

  2015cites this paper
• Ocular Hypotensive Activity of a Non-Peptide Bradykinin B2-Receptor Antagonist (WIN-64338) In Dutch-Belt Rabbits- A Case of Poly-Pharmacology in Action

  2015cites this paper
• Current perspective of neuroprotection and glaucoma

  2015cites this paper
• Comparison of Dorzolamide/Timolol Versus Brimonidine/Timolol Fixed Combination Therapy in the Management of Steroid-Induced Ocular Hypertension

  2015cites this paper
• Pharmacotherapy and Adherence Issues in Treating Elderly Patients with Glaucoma

  2015cites this paper
• Tafluprost/Timolol: A Review in Open-Angle Glaucoma or Ocular Hypertension

  2015cites this paper
• Cuidados, aspectos psicológicos y actividad física en relación con la salud

  2015cites this paper
• Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy

  2015cites this paper
• Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study

  2015cites this paper
• 57 – Fixed Combination Therapies in Glaucoma

  2015cites this paper
• Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension

  2014influential citation
• A 6-Month Study Comparing Efficacy, Safety, and Tolerability of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% versus Each of Its Individual Preservative-Free

  2014cites this paper
• Twice-daily brinzolamide/brimonidine fixed combination versus brinzolamide or brimonidine in open-angle glaucoma or ocular hypertension.

  2014cites this paper
• Glaucoma management: relative value and place in therapy of available drug treatments

  2014cites this paper
• Brinzolamide plus brimonidine for the treatment of glaucoma: an update

  2014cites this paper
• Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice

  2014cites this paper
• A 6-Month Study Comparing Efficacy, Safety, and Tolerability of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% versus Each of Its Individual Preservative-Free Components

  2014cites this paper
• Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus

  2014cites this paper
• A practical approach to ocular pain for the non-ophthalmologist.

  2014cites this paper
• Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension

  2014cites this paper
• Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension

  2014influential citation
• Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus

  2014cites this paper
• Randomized Trial of Brinzolamide/Brimonidine Versus Brinzolamide Plus Brimonidine for Open-Angle Glaucoma or Ocular Hypertension

  2014cites this paper
• Six-month results from a Phase III randomized trial of fixed-combination brinzolamide 1% + brimonidine 0.2% versus brinzolamide or brimonidine monotherapy in glaucoma or ocular hypertension

  2013cites this paper
• Combination Therapy in Glaucoma Treatment

  2013cites this paper